Pending Fosamax Lawsuits exceed 2,200 Cases in Court

According to court documents, more than 2,200 Fosamax lawsuits are pending in court by plaintiffs claiming they suffer femur fractures, jaw problems or other injuries from taking Fosamax. Fosamax, manufactured by Merck, belongs to the class of drugs known as bisphosphonates. It was approved by the FDA in 1995 and developed to treat post-menopausal osteoporosis and Paget's disease of bone. A study published online in May 2012, by the Archives of Internal Medicine, a publication of the American Medical Association, revealed that atypical femoral fractures were associated with bisphosphonate (including Fosamax) use. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Fosamax alleged severe adverse events. [http://www.attorneyone.com/fosamax/

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Fosamax: severe adverse events threat

Fosamax: severe adverse events threat

more than 2,200 Fosamax lawsuits are pending in court by plaintiffs claiming they suffer femur fractures, jaw problems or other injuries from taking Fosamax

San Diego, CA (PRWEB) October 23, 2012

The media spotlight is often a double-edged sword. No one knows this better than people who suffer from Fosamax adverse events. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

According to court documents, more than 2,200 Fosamax lawsuits are pending in court by plaintiffs claiming they suffer femur fractures, jaw problems or other injuries from taking Fosamax. Fosamax, manufactured by Merck, belongs to the class of drugs known as bisphosphonates. It was approved by the FDA in 1995 and developed to treat post-menopausal osteoporosis and Paget's disease of bone. Fosamax lawsuits filed in New Jersey state court are consolidated in the Multi District Litigation centralized before Judge Carol Higbee in the Superior Court for Atlantic County, New Jersey (MDL 282).

A study published online in May 2012, by the Archives of Internal Medicine, a publication of the American Medical Association, revealed that atypical femoral fractures were associated with bisphosphonate (including Fosamax) use.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of alleged severe adverse events from Fosamax, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that alleged threat from Fosamax remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

A study published in April 2012 on the Canadian Medical Association Journal (CMAJ) reveals that first-time use of oral bisphosphonates (including Fosamax) is associated with greater risk for two inflammatory eye diseases, uveitis and scleritis.

AttorneyOne.com has further information on Fosamax lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/10/prweb10023033.htm.